$12 Hollister Gray High Waist Denim Jean Shorts Hollister Shorts High Waist Hollister Gray High Waist shop Jean Shorts Denim $12 Hollister Gray High Waist Denim Jean Shorts Hollister Shorts High Waist Jean,Hollister,High,Gray,Shorts,welcome2oz.com,/cannoned1083662.html,Waist,Denim,$12,Hollister , Shorts , High Waist Hollister Gray High Waist shop Jean Shorts Denim Jean,Hollister,High,Gray,Shorts,welcome2oz.com,/cannoned1083662.html,Waist,Denim,$12,Hollister , Shorts , High Waist

Hollister Gray High Waist shop Selling Jean Shorts Denim

Hollister Gray High Waist Denim Jean Shorts

$12

Hollister Gray High Waist Denim Jean Shorts

98% Cotton, 2% Spandex Solid Frayed edges, Fringe & frayed accents Gray High rise waist
|||

Hollister Gray High Waist Denim Jean Shorts

Intro Pullout Text Widget

a leading international journal from BMJ and BSG, publishes cutting-edge gastroenterology and hepatology research and reviews

Impact Factor: 23.059
Citescore: 35.6
All metrics >>

Gut is a Plan S compliant Transformative Journal.

Gut is a leading international journal in gastroenterology and hepatology and has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage in all areas of gastroenterology and hepatology. Regular features include articles by leading authorities describing novel mechanisms of disease and new management strategies, both diagnostic and therapeutic, likely to impact on clinical practice within the foreseeable future.

Gut is an official journal of the British Society of Gastroenterology and has two companion titles: Frontline Gastroenterology for education and practice and BMJ Open Gastroenterology for sound science clinical research.

Editor-in-Chief: Professor Emad El-Omar, University of New South Wales, Sydney, Australia
Meet the Editor and Editorial Board

TOP CITED ARTICLES
Read the most cited articles from Gut and BMJ Open Gastroenterology

SOCIAL MEDIA AND MULTIMEDIA
Keep up-to-date with Gut on Twitter and Facebook, and access videos on our ow intimates body suit channel.

The Gut blog is now live - read the latest posts from the team.

Gut publishes podcasts discussing highlights from its issues. Subscribe in all podcast platforms, including Huf Longsleeve, Google Podcasts, INC Ruffle-Edge Metallic Evening Wrap and Spotify.

 

Women's Black Soft Sweatshirt Boat Neck Top

COVID-19 Gastroenterology Collection

 

Our new online collection highlights all research relating to the COVID-19 pandemic published by Gut, Frontline Gastroenterology and BMJ Open Gastroenterology. It is updated regularly as new articles are published.

 

The COVID-19 collection includes original research, commentaries, letters and editorials from all three journals published with the British Society of Gastroenterology (BSG)

 

Visit the full BMJ Coronavirus resource collection for all the latest content from across our portfolio

 

Latest Visual Abstract

Visual Abstracts provide summaries of the latest research in a single, visual format

View a high-resolution version of the Visual Abstract and read the full article

Altmetrics

Podcasts

Featured Video

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer

To cite: Sundar R, Barr Kumarakulasinghe N, Huak Chan Y, et al. Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial. Gut. 2022;71:676-685.

Read the full article here: link
Objective: To date, there are no predictive biomarkers to guide selection of patients with gastric cancer (GC) who benefit from paclitaxel. Stomach cancer Adjuvant Multi-Institutional group Trial (SAMIT) was a 2×2 factorial randomised phase III study in which patients with GC were randomised to Pac-S-1 (paclitaxel +S-1), Pac-UFT (paclitaxel +UFT), S-1 alone or UFT alone after curative surgery.

Conclusions: Using machine-learning techniques on one of the largest GC trials (SAMIT), we identify a gene signature representing the first predictive biomarker for paclitaxel benefit.

Related Content